Komipharm International Revenue

In the year 2025, Komipharm International had annual revenue of 52.47B KRW, down -10.74%. Komipharm International had revenue of 11.90B in the quarter ending December 31, 2025, a decrease of -24.38%.

Revenue

52.47B

Revenue Growth

-10.74%

P/S Ratio

13.84

Revenue / Employee

325.87M

Employees

161

Market Cap

726.31B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.47B	-6.31B	-10.74%
Dec 31, 2024	58.78B	16.13B	37.83%
Dec 31, 2023	42.65B	2.85B	7.15%
Dec 31, 2022	39.80B	3.95B	11.03%
Dec 31, 2021	35.85B	-1.31B	-3.53%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,814.00B
Celltrion	4,162.50B
ALTEOGEN	215.86B
Samsung Epis Holdings	1,510.14B
Huons Global	847.45B
JW Pharmaceutical	775.30B
Medy-Tox	247.29B
Curexo	74.53B

Revenue Rankings